Issued Patents All Time
Showing 1–16 of 16 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12383619 | Use of glutamate modulating agents with immunotherapies to treat cancer | — | 2025-08-12 |
| 12364687 | Use of riluzole oral disintegrating tablets for treating diseases | Robert Berman, Irfan Qureshi | 2025-07-22 |
| 12201618 | Use of riluzole prodrugs to treat Alzheimer's disease | Robert Berman, Irfan Qureshi | 2025-01-21 |
| 12161633 | Use of riluzole prodrugs to treat alzheimer's disease | Robert Berman, Irfan Qureshi | 2024-12-10 |
| 12121609 | Sublingual formulation of riluzole | Robert Berman, Ronald Vladyka, Amgad Saleh, Danny Yu | 2024-10-22 |
| 12102618 | Use of riluzole prodrugs to treat ataxias | Robert Berman, Melissa Beiner, Gilbert L'Italien | 2024-10-01 |
| 11965031 | Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment | Tibor Keler, Thomas A. Davis | 2024-04-23 |
| 11660267 | Sublingual formulation of riluzole | Robert Berman, Ronald Vladyka, Amgad Saleh, Danny Yu | 2023-05-30 |
| 11554117 | Glutamate agents in the treatment of mental disorders | John H. Krystal, Gerard Sanacora | 2023-01-17 |
| 11400155 | Use of riluzole, riluzole prodrugs or riluzole analogs with immunotherapies to treat cancers | — | 2022-08-02 |
| 11083724 | Rimegepant for CGRP related disorders | Robert Croop | 2021-08-10 |
| 10668152 | Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment | Tibor Keler, Thomas A. Davis | 2020-06-02 |
| 10392442 | Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment | Tibor Keler, Thomas A. Davis | 2019-08-27 |
| 10052318 | Glutamate agents in the treatment of mental disorders | John H. Krystal, Gerard Sanacora | 2018-08-21 |
| 8778979 | Glutamate agents in the treatment of mental disorders | John H. Krystal, Gerard Sanacora | 2014-07-15 |
| 7869010 | Method for evaluating purity and concentration of oils and fatty acid compositions | — | 2011-01-11 |